Séverac, F.
25  Ergebnisse:
Personensuche X
?
2

Incidence and Time-to-Onset of Carbapenemase-Producing Ente..:

Hoellinger, B ; Deboscker, S ; Danion, F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769894/.  , 2022
 
?
3

Incidence and Time-to-Onset of Carbapenemase-Producing Ente..:

B. Hoellinger ; S. Deboscker ; F. Danion...
https://journals.asm.org/doi/10.1128/spectrum.01868-22.  , 2022
 
?
5

And if we had to do it all over again, would we send medica..:

Pelaccia, T ; Sibilia, J ; Fels, É...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11739-020-02629-0.  , 2021
 
?
 
?
7

Postprocedural Antiplatelet Treatment after Emergent Caroti..:

Pop, R ; Hasiu, A ; Mangin, P.H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115381/.  , 2021
 
?
8

Évaluation d'un outil de mesure avec affichage de la norme ..:

Maretti-Reheis, L ; Séverac, F ; Favre, R.
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.gofs.2020.03.012.  , 2020
 
?
11

Factors associated with acquisition of glycopeptide-resista..:

Deboscker, S ; Schneider, P ; Severac, F...
info:eu-repo/semantics/altIdentifier/doi/10.1017/S0950268818003655.  , 2019
 
?
12

Factors associated with acquisition of glycopeptide-resista..:

Deboscker, S ; Schneider, P ; Severac, F...
info:eu-repo/semantics/altIdentifier/doi/10.1017/S0950268818003655.  , 2019
 
?
13

Factors associated with acquisition of glycopeptide-resista..:

Deboscker, S ; Schneider, P ; Severac, F...
info:eu-repo/semantics/altIdentifier/doi/10.1017/S0950268818003655.  , 2019
 
?
15

Predictors and Clinical Impact of Delayed Stent Thrombosis ..:

Pop, R ; Zinchenko, I ; Quenardelle, V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028646/.  , 2019
 
1-15